Context Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTX and other ETFs, options, and stocks.About CNTX
Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers.
CEOMartin A. Lehr
CEOMartin A. Lehr
Employees12
Employees12
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2015
Founded2015
Employees12
Employees12
CNTX Key Statistics
Market cap77.82M
Market cap77.82M
Price-Earnings ratio-1.65
Price-Earnings ratio-1.65
Dividend yield—
Dividend yield—
Average volume126.84K
Average volume126.84K
High today$0.8814
High today$0.8814
Low today$0.80
Low today$0.80
Open price$0.8814
Open price$0.8814
Volume70.47K
Volume70.47K
52 Week high$2.75
52 Week high$2.75
52 Week low$0.55
52 Week low$0.55
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CNTX. This list is generated using Robinhood data, and it’s not a recommendation.